Year-End Sale is Live! Find Exclusive Prices on the Best Selling Pharma & MedTech Reports. Check Now!
Jan 02, 2018
British scientists looking forward to treat Alzheimer’s disease through diabetes drug
A group of British scientists are looking for the treatment of Alzheimer’s disease in an unlikely source i.e. a drug used for treating Type 2 Diabetes. The team, from Lancaster University, has reported that an experimental three-part drug initially developed for treating Type 2 diabetes has shown positive results in reversing the memory loss in mice.
Article in PDF
Bioengineers are trying to mimic natural development through 3D printing for developing complex living tissues
The field of tissue engineering has achieved a completely new level after the use of 3D printing came into the process to grow complex human tissues like bone and muscle. Although these structures lack the complexity of real human tissues at this stage. So, bioengineers at the University of California are trying a completely different approach: They’re only recreating the early stage development and leaving the rest up to cells to grow themselves into the necessary structures.
CAR-T therapy under testing to see possible potential in curing HIV
Engineered immune cells known as chimeric antigen receptor T cells (CAR-T) were in the headlines last year for their potential to cure some patients suffering from the life-threatening diseases like leukemia and lymphoma. But now CAR-T has again become a hot topic for its possible potential beyond cancer, scientists at the University of California at Los Angeles are investigating whether the approach can be used for fighting against HIV too.
CRISPR technique under development to prevent the hearing loss
Approximately 50% of all cases of deafness are caused by some genetic defect. Due to this high number now the scientists are testing the emerging gene-editing technique CRISPR-Cas9 for its potential to prevent hearing loss in people who inherit those genes. A group of Scientists at the Howard Hughes Medical Institute are looking to use CRISPR in treating genetic deafness. They have their first evidence that this technique may hold promising results.
Article in PDF